These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 581525
1. [Tolerance and contrast density in intravenous cholangiography and cholecystography using a new contrast medium (author's transl)]. Siemers M, Schäfer K, Menges G, Horst H. Rontgenblatter; 1978 Oct; 31(10):596-9. PubMed ID: 581525 [Abstract] [Full Text] [Related]
2. [Clinical experiences with iodoxamic acid in the cholecystography-cholangiography (author's transl)]. Keiner F. Med Klin; 1976 Oct 29; 71(44):1885-90. PubMed ID: 1036604 [Abstract] [Full Text] [Related]
3. [Clinical experience with a new intravenous contrast medium, BC-17 in cholecystography and cholangiography (author's transl)]. Inamoto K, Miyoshi K. Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Oct 25; 34(10):725-34. PubMed ID: 4533780 [No Abstract] [Full Text] [Related]
4. [Endomirabil, a new contrast medium for the biliary tract. Rate of adverse effects with special reference to the application time]. Barner L, Kurzen S. Med Welt; 1977 Apr 29; 28(17):817-9. PubMed ID: 577589 [No Abstract] [Full Text] [Related]
5. [Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)]. Schmerwitz W, Rösch E. Rontgenblatter; 1977 Feb 29; 30(2):71-8. PubMed ID: 576505 [Abstract] [Full Text] [Related]
6. [Cholangiography and cholecystography with a new water-soluble contrast medium (BC-17) by intravenous drip infusion (II). Effects on tests of thyroid function (author's transl)]. Tanimura H, Ishii K, Fujimura M, Matsuda M. Nihon Geka Hokan; 1974 Nov 01; 43(6):476-85. PubMed ID: 4480399 [No Abstract] [Full Text] [Related]
7. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)]. Kölling K, Hoenle R, Korsten FW. Radiologe; 1977 Feb 01; 17(2):70-3. PubMed ID: 322198 [Abstract] [Full Text] [Related]
8. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects]. Schmerwitz W. Rontgenblatter; 1977 Feb 01; 30(2):64-70. PubMed ID: 576504 [Abstract] [Full Text] [Related]
9. [Drip infusion cholecysto-cholangiography with iodoxamate (BC-17) (III). Especially, compared with iodipamide (author's transl)]. Tanimura H, Takenaka M, Setoyama M, Kamata T. Nihon Geka Hokan; 1977 May 01; 46(3):313-25. PubMed ID: 578092 [No Abstract] [Full Text] [Related]
13. [Modern X-ray contrast media applicable to intravenous cholangiocholecystography (review of the literature)]. Sviridov NK, Popova ZP, Varfolomeeva VN, Mikhaĭlova NA. Farmakol Toksikol; 1981 May 01; 44(2):245-7. PubMed ID: 7023971 [No Abstract] [Full Text] [Related]
14. Urography with non-ionic contrast media: I. Diagnostic quality and tolerance of iohexol in comparison with meglumine amidotrizoate. Taenzer V, Heep H, Clauss W. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983 May 01; 118():148-52. PubMed ID: 6139070 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation of a new contrast medium for cholegraphy]. Németh A. Schweiz Rundsch Med Prax; 1976 Jul 06; 65(27):846-52. PubMed ID: 1036621 [No Abstract] [Full Text] [Related]
16. A new contrast medium for cholangio-cholecystography: meglumine iodoxamete. Sargent EN, Schulman A, Meyers HI, Gutler RB, Nicoloff JT, DiFazio LT. Am J Roentgenol Radium Ther Nucl Med; 1975 Sep 06; 125(1):251-8. PubMed ID: 1242871 [Abstract] [Full Text] [Related]